flurbiprofen has been researched along with eye in 21 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 9 (42.86) | 18.7374 |
| 1990's | 3 (14.29) | 18.2507 |
| 2000's | 5 (23.81) | 29.6817 |
| 2010's | 4 (19.05) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Mushin, A; Williams, H; Zutshi, D | 1 |
| Takase, M; Tsuchisaka, H | 1 |
| Araie, M; Takase, M | 1 |
| Rosenbaum, JT; Rubin, RM | 1 |
| Anderson, JA; Chen, CC | 1 |
| Liu, S; Tang-Liu, DD | 1 |
| Liu, SS; Tang-Liu, DD; Weinkam, RJ | 1 |
| Bito, LZ; Klein, EM | 1 |
| Anderson, JA; Chen, CC; Shackleton, M; Vita, JB | 1 |
| Glasius, E; Noach, EL; Oosterhuis, JA; van Delft, JL; van Haeringen, NJ | 1 |
| Lee, DA; Nguyen, KD | 1 |
| Ward, DA | 1 |
| Martin, W; McNeish, AJ; Wilson, WS | 1 |
| Bucolo, C; Maltese, A; Pignatello, R; Puglisi, G; Spedalieri, G | 1 |
| Harris, LC; Kulkarni, KH; Leday, AM; Ohia, SE; Opere, CA; Roche, VF; Zhan, GL | 1 |
| Egea, MA; Espina, M; García, ML; Valls, O; Vega, E | 1 |
| Araújo, J; Egea, MA; Garcia, ML; Lopes, C; Souto, EB; Vega, E | 1 |
| Egea, MA; Garcia, ML; Gonzalez-Mira, E; Souto, EB | 1 |
| Calpena, AC; Egea, MA; García, ML; Gonzalez-Mira, E; Souto, EB | 1 |
| Maranda, LS; Pirie, CG; Pizzirani, S | 1 |
| KuKanich, B; Lanuza, R; Meekins, JM; Rankin, AJ | 1 |
3 trial(s) available for flurbiprofen and eye
| Article | Year |
|---|---|
Effects of S-596 and carteolol, new beta-adrenergic blockers, and flurbiprofen on the human eye: a fluorophotometric study.
Topics: Adrenergic beta-Antagonists; Adult; Carteolol; Eye; Female; Fluorescein; Fluoresceins; Flurbiprofen; Humans; Male; Photometry; Propanolamines; Propionates | 1985 |
Effect of topical 0.03% flurbiprofen and 0.005% latanoprost, alone and in combination, on normal canine eyes.
Topics: Acclimatization; Animals; Anti-Inflammatory Agents, Non-Steroidal; Cross-Over Studies; Dogs; Eye; Flurbiprofen; Intraocular Pressure; Latanoprost; Neuroprotective Agents; Prostaglandins F, Synthetic; Pupil; Time Factors | 2011 |
Evaluation of systemic absorption and renal effects of topical ophthalmic flurbiprofen and diclofenac in healthy cats.
Topics: Absorption, Physiological; Administration, Ophthalmic; Animals; Cats; Cyclooxygenase Inhibitors; Diclofenac; Eye; Female; Flurbiprofen; Male; Ophthalmic Solutions | 2016 |
18 other study(ies) available for flurbiprofen and eye
| Article | Year |
|---|---|
Ophthalmic screening of patients receiving ketoprofen or flurbiprofen medication for inflammatory and degenerative joint diseases.
Topics: Adult; Aged; Analgesics; Arthritis; Benzophenones; Cornea; Eye; Female; Flurbiprofen; Follow-Up Studies; Humans; Joint Diseases; Ketoprofen; Lens, Crystalline; Male; Middle Aged; Propionates; Retina; Time Factors; Visual Acuity | 1976 |
Topical flurbiprofen in intraocular surgery on diabetic and nondiabetic patients.
Topics: Administration, Topical; Adult; Aged; Aged, 80 and over; Cataract; Cataract Extraction; Cyclooxygenase Inhibitors; Diabetes Complications; Eye; Female; Flurbiprofen; Humans; Inflammation; Intraocular Pressure; Male; Middle Aged; Ophthalmic Solutions; Postoperative Care; Premedication; Pupil; Visual Acuity | 1990 |
A platelet-activating factor antagonist inhibits interleukin 1-induced inflammation.
Topics: Animals; Aqueous Humor; Capillary Permeability; Dinoprostone; Eye; Female; Flurbiprofen; Inflammation; Interleukin-1; Leukocyte Count; Platelet Activating Factor; Prednisolone; Prostaglandins E; Proteins; Quinolinium Compounds; Rabbits; Recombinant Proteins | 1988 |
Multiple dosing increases the ocular bioavailability of topically administered flurbiprofen.
Topics: Animals; Biological Availability; Dose-Response Relationship, Drug; Eye; Female; Flurbiprofen; Ophthalmic Solutions; Propionates; Rabbits; Tissue Distribution | 1988 |
Relationship between the ocular and systemic disposition of flurbiprofen: the effect of altered protein dynamics at steady state.
Topics: Animals; Aqueous Humor; Blood Proteins; Chromatography, High Pressure Liquid; Eye; Female; Flurbiprofen; Propionates; Protein Binding; Rabbits; Tissue Distribution | 1987 |
Ocular and systemic bioavailability of ophthalmic flurbiprofen.
Topics: Administration, Topical; Animals; Aqueous Humor; Biological Availability; Chromatography, Liquid; Eye; Eye Proteins; Female; Flurbiprofen; Injections, Intravenous; Ophthalmic Solutions; Propionates; Rabbits | 1984 |
The role of the arachidonic acid cascade in the species-specific X-ray-induced inflammation of the rabbit eye.
Topics: Animals; Arachidonic Acids; Cromolyn Sodium; Endophthalmitis; Eye; Female; Flurbiprofen; Imidazoles; Indomethacin; Intraocular Pressure; Male; Prednisolone; Prostaglandins; Rabbits; Radiation Injuries, Experimental; Species Specificity; Vitamin E | 1982 |
Disposition of topical flurbiprofen in normal and aphakic rabbit eyes.
Topics: Absorption; Animals; Aphakia, Postcataract; Cataract Extraction; Choroid; Cornea; Disease Models, Animal; Eye; Female; Flurbiprofen; Propionates; Rabbits; Retina; Vitreous Body | 1982 |
A comparison of the effects of non-steroidal compounds on the disruption of the blood-aqueous barrier.
Topics: Animals; Anti-Inflammatory Agents; Aqueous Humor; Diclofenac; Eye; Eye Proteins; Flurbiprofen; Hydrogen-Ion Concentration; Indomethacin; Rabbits | 1982 |
In vitro evaluation of antiproliferative potential of topical cyclooxygenase inhibitors in human Tenon's fibroblasts.
Topics: Anti-Inflammatory Agents, Non-Steroidal; Cell Adhesion; Connective Tissue; Cyclooxygenase Inhibitors; Diclofenac; Dose-Response Relationship, Drug; Evaluation Studies as Topic; Eye; Fibroblasts; Flurbiprofen; Humans; Mitosis; Piroxicam; Suprofen | 1993 |
Comparative efficacy of topically applied flurbiprofen, diclofenac, tolmetin, and suprofen for the treatment of experimentally induced blood-aqueous barrier disruption in dogs.
Topics: Animals; Anterior Chamber; Anti-Inflammatory Agents, Non-Steroidal; Blood-Aqueous Barrier; Diclofenac; Dogs; Eye; Fluorescein; Fluoresceins; Fluorophotometry; Flurbiprofen; Ocular Physiological Phenomena; Ophthalmic Solutions; Random Allocation; Suprofen; Tolmetin | 1996 |
Dominant role of an endothelium-derived hyperpolarizing factor (EDHF)-like vasodilator in the ciliary vascular bed of the bovine isolated perfused eye.
Topics: 15-Hydroxy-11 alpha,9 alpha-(epoxymethano)prosta-5,13-dienoic Acid; Acetylcholine; Animals; Barium; Biological Factors; Blood Vessels; Bradykinin; Cattle; Charybdotoxin; Ciliary Body; Dose-Response Relationship, Drug; Endothelium, Vascular; Enzyme Inhibitors; Eye; Flurbiprofen; Glyburide; In Vitro Techniques; NG-Nitroarginine Methyl Ester; Ouabain; Oxadiazoles; Perfusion; Potassium; Potassium Channel Blockers; Pressure; Quinoxalines; Tetraethylammonium; Vasoconstrictor Agents; Vasodilation; Vasodilator Agents | 2001 |
Flurbiprofen-loaded acrylate polymer nanosuspensions for ophthalmic application.
Topics: Acrylic Resins; Animals; Anti-Inflammatory Agents, Non-Steroidal; Biocompatible Materials; Biological Availability; Eye; Flurbiprofen; Humans; In Vitro Techniques; Materials Testing; Miosis; Nanotechnology; Ophthalmic Solutions; Rabbits | 2002 |
Ocular pharmacology of bicyclic hexahydroaporphines.
Topics: Animals; Aporphines; Bridged Bicyclo Compounds; Cattle; Cyclooxygenase Inhibitors; Eye; Flurbiprofen; In Vitro Techniques; Intraocular Pressure; Iris; Male; Muscle, Smooth; Ocular Hypotension; Rabbits | 2005 |
Flurbiprofen loaded biodegradable nanoparticles for ophtalmic administration.
Topics: Animals; Anti-Inflammatory Agents, Non-Steroidal; Biotransformation; Buffers; Drug Compounding; Electrochemistry; Eye; Flurbiprofen; Irritants; Lactic Acid; Nanoparticles; Ophthalmic Solutions; Particle Size; Phosphates; Polyglycolic Acid; Polylactic Acid-Polyglycolic Acid Copolymer; Polymers; Rabbits; Solutions; Surface-Active Agents | 2006 |
Effect of polymer viscosity on physicochemical properties and ocular tolerance of FB-loaded PLGA nanospheres.
Topics: Analysis of Variance; Animals; Chemical Phenomena; Chickens; Drug Delivery Systems; Drug Tolerance; Eye; Flurbiprofen; Hydrogen-Ion Concentration; Microscopy, Electron, Transmission; Nanospheres; Particle Size; Polyglactin 910; Reference Standards; Surface Properties; Time Factors; Viscosity | 2009 |
Design and ocular tolerance of flurbiprofen loaded ultrasound-engineered NLC.
Topics: Animal Testing Alternatives; Animals; Anti-Inflammatory Agents, Non-Steroidal; Castor Oil; Drug Carriers; Drug Design; Drug Stability; Drug Tolerance; Eye; Flurbiprofen; Irritants; Nanoparticles; Particle Size; Polysorbates; Predictive Value of Tests; Rabbits; Skin Irritancy Tests; Stearic Acids; Surface Properties; Tissue Engineering; Ultrasonics | 2010 |
Optimizing flurbiprofen-loaded NLC by central composite factorial design for ocular delivery.
Topics: Administration, Topical; Animals; Anti-Inflammatory Agents, Non-Steroidal; Crystallization; Drug Carriers; Drug Stability; Eye; Flurbiprofen; Lipids; Nanostructures; Ophthalmic Solutions; Particle Size; Rabbits | 2011 |